Investigators designed this study to evaluate the feasibility and potential utility of a peer-led CBT-based workshop for PPD.
Lauren McDermott, a patient living with atypical SPS, shares her journey from receiving an official diagnosis to the treatments that help her manage her condition.
The Wake Up America Survey is an annual online survey conducted in partnership with The Harris Poll.
In an expert roundtable, clinicians discuss the risks, benefits, and anticipated real-world usage of lecanemab following US FDA approval.
Robyn Tiger, MD, radiologist and founder of StressFreeMD, talks about physician burnout and strategies for addressing stress-related illness.
Marinos Dalakas, MD, discusses the etiology, diagnosis, and treatment of stiff person syndrome (SPS), and the future of SPS research.
Research findings support the use of vitamin D supplementation to help slow cognitive decline in Alzheimer dementia and reduce Parkinson disease symptom severity.
These are the clinical trials that led to the FDA’s approval of aducanumab and lecanemab for early AD, plus, the concerns that loom.
Mehdi Jorfi, PhD, discusses the opportunities to optimize the development and application of neurotechnologies for AD.
Findings published in 2020 suggest that irregular sleep schedules may increase CVD risk independent of sleep quality or duration.